PanagiotisVlachostergiosMDPhD

Genitourinary Oncology

Assistant Professor of Clinical Medicine, Weill Cornell Medicine, Meyer Cancer Center. Assistant Attending, New York Presbyterian Brooklyn Methodist Hospital

Join to view full profile

Dr. Vlachostergios is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vlachostergios' full profile

Already have an account?

Office
501 Sixth Street, Wesley House #3C
Brooklyn, NY 11215
Phone+1 718-780-5824

Fax+1 718-780-5545

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2016 - 2019
NYU Grossman School of Medicine/Brooklyn CampusResidency, Internal Medicine, 2013 - 2016
OtherClass of 2007, M.D., Magna Cum Laude

Certifications & Licensure

NY State Medical License 2016 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Conquer Cancer Foundation ASCO Merit Award ASCO, 2018-2019
Scott Wadler Memorial Fellow Clinical Research Award Weill Cornell Medical College, 2018-2019
Rising Star in Oncology Society of Translational Oncology (STO), 2018
John Quale Travel Fellowship Award Bladder Cancer Advocacy Network, 2018
Charles, Lilian and Betty Neuwirth Foundation Fellowship in Oncology Award Charles, Lilian and Betty Neuwirth Foundation, 2018
Outstanding Achievement and Dedication to Research New York University School of Medicine - Brooklyn Campus, Department of Medicine, 2016
Outstanding Leadership and Dedication as Chief Medical Resident New York University School of Medicine - Brooklyn Campus, Department of Medicine, 2016
Henry Christian Award American Federation for Medical Research, 2015
Best Poster Presentation award: Endothelin 1 and Nuclear factor kappa B are directly related in hormone naïve prostate cancer and predict biochemical recurrence after radical prostatectomy Genitourinary Oncology Section of the Hellenic Urologic Association, 2011
Join now to see all

Publications & Presentations

PubMed

29 citations
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer
Fadi Taza, Albert E Holler, Wei Fu, Hao Wang, Nabil Adra
JCO Precision Oncology. 2021-07-22
4 citations
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.
Jacob J Orme, Fadi Taza, Navonil De Sarkar, Alok K Tewari, Syed Arsalan Naqvi
European Urology Oncology. 2024-08-01
135 citations
Emerging Variants of Castration-Resistant Prostate Cancer
Panagiotis J. Vlachostergios, Loredana Puca, Himisha Beltran
Current Oncology Reports. 2017-05-01

Lectures

Association of noninvasive, radiographic measurement of prostate-specific membrane antigen (PSMA) expression with response to PSMA-targeted radionuclide therapy (TRT).
2019 ASCO Annual Meeting - 6/1/2019
Multi-gene hereditary cancer testing, family history and prognosis in men with prostate cancer.
2019 ASCO Annual Meeting - 6/1/2019